Document:

EX-10.6.1

 Exhibit 10.6.1 

PHASEBIO PHARMACEUTICALS, INC. 

SEVERANCE BENEFIT PLAN 

Section 1. INTRODUCTION. 

The PhaseBio Pharmaceuticals, Inc. Severance Benefit Plan (the “Plan”) is hereby established by the Board of Directors
of PhaseBio Pharmaceuticals, Inc. (the “Company”) effective upon the IPO Date (as defined below). The purpose of the Plan is to provide for the payment of severance benefits to eligible employees of the Company in the
event that such employees become subject to involuntary or constructive employment terminations. This Plan document also is the Summary Plan Description for the Plan. 

For purposes of the Plan, the following terms are defined as follows: 

(a) “Affiliate” means any corporation (other than the Company) in an “unbroken chain of corporations”
beginning with the Company, if each of the corporations other than the last corporation in the unbroken chain owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such
chain. 
 (b) “Base Salary” means base pay (excluding incentive pay, premium pay, commissions, overtime,
bonuses and other forms of variable compensation) as in effect prior to any reduction that would give rise to an employee’s right to a resignation for Good Reason (if applicable). 

(c) “Cause” means, with respect to a particular employee, the meaning ascribed to such term in any written
employment agreement, offer letter or similar agreement between such employee and the Company defining such term, and, in the absence of such agreement, means with respect to such employee, the term “Cause” as defined in the Equity Plan.
The determination whether a termination is for Cause shall be made by the Plan Administrator in its sole and exclusive judgment and discretion. 

(d) “Change in Control” has the meaning ascribed to such term in the Equity Plan. 

(e) “Change in Control Period” means the period commencing one month prior to the Closing of a Change in Control
and ending 12 months following the Closing of a Change in Control. 
 (f) “Closing” means the initial closing
of the Change in Control as defined in the definitive agreement executed in connection with the Change in Control. In the case of a series of transactions constituting a Change in Control, “Closing” means the first closing that satisfies
the threshold of the definition for a Change in Control. 
 (g) “Code” means the Internal Revenue Code of
1986, as amended, including any applicable regulations and guidance thereunder. 
 (h) “Committee” means the
Board of Directors or the Compensation Committee of the Board of Directors of the Company. 

 (i) “Company” means PhaseBio Pharmaceuticals, Inc. or,
following a Change in Control, the surviving entity resulting from such event. 
 (j) “Confidentiality
Agreement” means the Company’s standard form of Employee Invention Assignment and Confidentiality Agreement or any similar or successor document. 

(k) “Covered Termination” means, with respect to an employee, a termination of employment that is due to
(1) a termination by the Company without Cause (and other than as a result of the employee’s death or Disability) or (2) the employee’s resignation for Good Reason, and in either case of (1) or (2), results in such
employee’s Separation from Service. 
 (l) “Disability” means any physical or mental condition which
renders an employee incapable of performing the work for which he or she was employed by the Company or similar work offered by the Company. The Disability of an employee shall be established if (i) the employee satisfies the requirements
for benefits under the Company’s long-term disability plan or (ii) if no long-term disability plan, the employee satisfies the requirements for Social Security disability benefits. 

(m) “Eligible Employee” means an employee of the Company that meets the requirements to be eligible to receive
Plan benefits as set forth in Section 2. 
 (n) “Equity Plan” means the PhaseBio Pharmaceuticals, Inc.
2018 Equity Incentive Plan, as amended from time to time. 
 (o) “Good Reason” for an employee’s
resignation means the occurrence of any one or more of the following are undertaken by the Company (or successor to the Company, if applicable) without the employee’s express written consent: 

(1) a material reduction in a such employee’s annual base salary, representing a reduction of more than ten percent (10%) of such
employee’s then current base salary; provided, that an across-the-board reduction in the salary level of all similarly situated employees of the Company by
the same percentage amount as part of a general salary level reduction shall not constitute such a material salary reduction; 
 (2)
a material reduction or material adverse change in such employee’s job duties, responsibilities or authority; provided, however, that any such reduction or change after a Change in Control (or similar corporate transaction that does not
constitute a Change in Control) shall not constitute Good Reason by virtue of the fact that such employee is performing similar duties and responsibilities in a larger organization; 

(3) a relocation of such employee’s principal place of employment with the Company (or successor to the Company, if applicable) to
a place that increases such employee’s one-way commute by more than 50 miles as compared to such employee’s then-current principal place of employment immediately prior to such relocation, except for
required travel by the employee on the Company’s business to an extent substantially consistent with employee’s business travel obligations prior to the effective date of the Change in Control (or similar transaction); or 

  
 2. 

 (4) a material breach by the Company of any provision of this Plan or any other
material agreement between such employee and the Company concerning the terms and conditions of such employee’s employment or service with the Company, 

provided, however, that in any case of (1), (2), (3) or (4) above, in order for the employee’s resignation to be deemed to
have been for Good Reason, (i) the employee must first give the Company written notice of such employee’s intent to resign for Good Reason within 60 days after the date on which the Company gives written notice to such employee of the
Company’s affirmative decision to take an action set forth in clause (1), (2), (3), or (4) above (or such action or condition otherwise occurs), which notice shall describe such condition(s) employee believes constitute Good Reason;
(ii) the Company must fail to remedy such condition(s) within 30 days after receipt of such written notice (the “Cure Period”), and (iii) the employee must resign from employment effective not later than
30 days after the expiration of such Cure Period. 
 (p) “IPO Date” means the date of the underwriting
agreement between the Company and the underwriter(s) managing the initial public offering of the Company’s Common Stock, pursuant to which the Common Stock is priced for the initial public offering. 

(q) “Participation Agreement” means an agreement between an employee and the Company in substantially the form
of APPENDIX A attached hereto, and which may include such other terms as the Committee deems necessary or advisable in the administration of the Plan. 

(r) “Plan Administrator” means the Committee prior to the Closing and the Representative upon and following the
Closing, as applicable. 
 (s) “Representative” means one or more members of the Committee or other persons or
entities designated by the Committee prior to or in connection with a Change in Control that will have authority to administer and interpret the Plan upon and following the Closing as provided in Section 8(a). 

(t) “Section 409A” means Section 409A of the Code and the treasury
regulations and other guidance thereunder and any state law of similar effect. 
 (u) “Separation from
Service” means a “separation from service” within the meaning of Treasury Regulations Section 1.409A-1(h), without regard to any alternative definition thereunder. 

Section 2. ELIGIBILITY FOR BENEFITS. 

(a) Eligible Employee. An employee of the Company is eligible to participate in the Plan if (i) the Plan Administrator has
designated such employee as eligible to participate in the Plan by providing such employee a Participation Agreement; (ii) such employee has signed and returned such Participation Agreement to the Company within the time period required
therein; and (iii) such employee meets the other Plan eligibility requirements set forth in this Section 2. The determination of whether an employee is an Eligible Employee shall be made by the Plan Administrator, in its sole discretion,
and such determination shall be binding and conclusive on all persons. 

  
 3. 

 (b) Release Requirement. Except as otherwise provided in an individual
Participation Agreement, in order to be eligible to receive benefits under the Plan, the employee also must execute a general waiver and release, in such a form as provided by the Company (the “Release”), within the
applicable time period set forth therein, and such Release must become effective in accordance with its terms, which must occur in no event more than 60 days following the date of the applicable Covered Termination. 

(c) Plan Benefits Provided In Lieu of Any Previous Benefits. This Plan shall supersede any change in control or severance benefit
plan, policy or practice previously maintained by the Company with respect to an Eligible Employee and any change in control or severance benefits in any individually negotiated employment contract or other agreement between the Company and an
Eligible Employee. Notwithstanding the foregoing, the Eligible Employee’s outstanding equity awards shall remain subject to the terms the Equity Plan or other applicable equity plan under which such awards were granted (including the award
documentation governing such awards) that may apply upon a Change in Control and/or termination of such employee’s service and no provision of this Plan shall be construed as to limit the actions that may be taken, or to violate the terms,
thereunder. 
 (d) Exceptions to Severance Benefit Entitlement. An employee who otherwise is an Eligible Employee will not
receive benefits under the Plan in the following circumstances, as determined by the Plan Administrator in its sole discretion: 

(1) The employee is terminated by the Company for any reason (including due to the employee’s death or Disability) or voluntarily
terminates employment with the Company in any manner, and in either case, such termination does not constitute a Covered Termination. Voluntary terminations include, but are not limited to, resignation, retirement or failure to return from a leave
of absence on the scheduled date. 
 (2) The employee voluntarily terminates employment with the Company in order to accept
employment with another entity that is wholly or partly owned (directly or indirectly) by the Company or an Affiliate. 
 (3) The
employee is offered an identical or substantially equivalent or comparable position with the Company or an Affiliate. For purposes of the foregoing, a “substantially equivalent or comparable position” is one that provides the employee
substantially the same level of responsibility and compensation and would not give rise to the employee’s right to a resignation for Good Reason. 

(4) The employee is offered immediate reemployment by a successor to the Company or an Affiliate or by a purchaser of the
Company’s assets, as the case may be, following a Change in Control and the terms of such reemployment would not give rise to the employee’s right to a resignation for Good Reason. For purposes of the foregoing, “immediate
reemployment” means that the employee’s employment with the successor to the Company or an Affiliate or the purchaser of its assets, as the case may be, results in uninterrupted employment such that the employee does not incur a
lapse in pay or benefits as a result of the change in ownership of the Company or the sale of its assets. For the avoidance of doubt, an employee who becomes immediately reemployed as described in this Section 2(d)(4) by a successor to the

  
 4. 

 Company or an Affiliate or by a purchaser of the Company’s assets, as the case may be, following a
Change in Control shall continue to be an Eligible Employee following the date of such reemployment. 
 (5) The employee is rehired
by the Company or an Affiliate and recommences employment prior to the date severance benefits under the Plan are scheduled to commence. 

(e) Termination of Severance Benefits. An Eligible Employee’s right to receive severance benefits under this Plan shall
terminate immediately if, at any time prior to or during the period for which the Eligible Employee is receiving severance benefits under the Plan, the Eligible Employee 

(1) willfully breaches any material statutory, common law, or contractual obligation to the Company or an Affiliate (including, without
limitation, the contractual obligations set forth in the Confidentiality Agreement and any other confidentiality, non-disclosure and developments agreement,
non-competition, non-solicitation, or similar type agreement between the Eligible Employee and the Company, as applicable). 

(2) fails to enter into the terms of the Confidentiality Agreement; 

(3) without the prior written approval of the Plan Administrator, engages in a Prohibited Action (as defined below). In addition, if
benefits under the Plan have already been paid to Eligible Employee and the Eligible Employee subsequently engages in a Prohibited Action during the Prohibited Period (or it is determined that an Eligible Employee engaged in a Prohibited Action
prior to receipt of such benefits), any benefits previously paid to the Eligible Employee shall be subject to recoupment by the Company on such terms and conditions as shall be determined by the Plan Administrator, in its sole discretion. The
“Prohibited Period” shall commence on the date of the Employee’s Covered Termination and continue for the number of months corresponding to the Severance Period set forth in such Eligible Employee’s Participation
Agreement. A “Prohibited Action” shall occur if the Eligible Employee: (i) breaches a material provision of the Confidentiality Agreement and/or any obligations of confidentiality,
non-solicitation, non-disparagement, no conflicts or non-competition set forth in the Eligible Employee’s employment
agreement, offer letter, any other written agreement between the Eligible Employee and the Company, or under applicable law; (ii) encourages or solicits any of the Company’s then current employees to leave the Company’s employ for any
reason or interferes in any other manner with employment relationships at the time existing between the Company and its then current employees; or (iii) induces any of the Company’s then current clients, customers, suppliers, vendors,
distributors, licensors, licensees, or other third parties to terminate their existing business relationship with the Company or interferes in any other manner with any existing business relationship between the Company and any then current client,
customer, supplier, vendor, distributor, licensor, licensee, or other third parties. 

  
 5. 

 Section 3. AMOUNT OF BENEFITS. 

(a) Benefits in Participation Agreement. Benefits under the Plan shall be provided to an Eligible Employee as set forth in the
Participation Agreement. 
 (b) Additional Benefits. Notwithstanding the foregoing, the Committee may, in its sole discretion,
provide benefits to individuals who are not Eligible Employees (“Non-Eligible Employees”) chosen by the Plan Administrator, in its sole discretion, and the provision of any such
benefits to a Non-Eligible Employee shall in no way obligate the Company to provide such benefits to any other individual, even if similarly situated. If benefits under the Plan are provided to a Non-Eligible Employee, references in the Plan to “Eligible Employee” (and similar references) shall be deemed to refer to such Non-Eligible Employee. 

(c) Certain Reductions. In addition to Section 2(e) above, the Company, in its sole discretion, shall have the authority to
reduce an Eligible Employee’s severance benefits, in whole or in part, by any other severance benefits, pay and benefits provided during a period following written notice of a business closing or mass layoff, pay and benefits in lieu of such
notice, or other similar benefits payable to the Eligible Employee by the Company or an Affiliate that become payable in connection with the Eligible Employee’s termination of employment pursuant to (i) any applicable legal requirement,
including, without limitation, the Worker Adjustment and Retraining Notification Act or any other similar state law or (ii) any Company policy or practice providing for the Eligible Employee to remain on the payroll for a limited period of time
after being given notice of the termination of the Eligible Employee’s employment, and the Plan Administrator shall so construe and implement the terms of the Plan. Any such reductions that the Company determines to make pursuant to this
Section 3(c) shall be made such that any severance benefit under the Plan shall be reduced solely by any similar type of benefit under such legal requirement, agreement, policy or practice (i.e., any cash severance benefits under the
Plan shall be reduced solely by any cash payments or severance benefits under such legal requirement, agreement, policy or practice). The Company’s decision to apply such reductions to the severance benefits of one Eligible Employee and the
amount of such reductions shall in no way obligate the Company to apply the same reductions in the same amounts to the severance benefits of any other Eligible Employee. In the Company’s sole discretion, such reductions may be applied on a
retroactive basis, with severance benefits previously paid being re-characterized as payments pursuant to the Company’s statutory obligation. 

(d) Parachute Payments. If any payment or benefit an Eligible Employee will or may receive from the Company or otherwise (a
“Payment”) would (i) constitute a “parachute payment” within the meaning of Section 280G of the Code, and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the
Code (the “Excise Tax”), then any such Payment shall be equal to the Reduced Amount. The “Reduced Amount” shall be either (x) the largest portion of the Payment that would result in no portion of
the Payment (after reduction) being subject to the Excise Tax or (y) the largest portion, up to and including the total, of the Payment, whichever amount (i.e., the amount determined by clause (x) or by clause (y)), after taking into
account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in the Eligible Employee’s receipt, on an
after-tax basis, of the greater economic benefit notwithstanding that all or some portion of the Payment may be subject to the Excise Tax. If a reduction in a Payment is required pursuant to

  
 6. 

 
the preceding sentence and the Reduced Amount is determined pursuant to clause (x) of the preceding sentence, the reduction shall occur in the manner (the “Reduction
Method”) that results in the greatest economic benefit for the Eligible Employee. If more than one method of reduction will result in the same economic benefit, the items so reduced will be reduced pro rata (the “Pro Rata
Reduction Method”). 
 Notwithstanding any provisions in this Section above to the contrary, if the Reduction Method or the Pro
Rata Reduction Method would result in any portion of the Payment being subject to taxes pursuant to Section 409A that would not otherwise be subject to taxes pursuant to Section 409A, then the Reduction Method and/or the Pro Rata Reduction
Method, as the case may be, shall be modified so as to avoid the imposition of taxes pursuant to Section 409A as follows: (A) as a first priority, the modification shall preserve to the greatest extent possible, the greatest economic
benefit for the Eligible Employee as determined on an after-tax basis; (B) as a second priority, Payments that are contingent on future events (e.g., being terminated without Cause), shall be
reduced (or eliminated) before Payments that are not contingent on future events; and (C) as a third priority, Payments that are “deferred compensation” within the meaning of Section 409A shall be reduced (or eliminated) before
Payments that are not deferred compensation within the meaning of Section 409A. 
 The Company shall appoint a nationally recognized
accounting or law firm to make the determinations required by this Section. The Company shall bear all expenses with respect to the determinations by such accounting or law firm required to be made hereunder. If the Eligible Employee receives a
Payment for which the Reduced Amount was determined pursuant to clause (x) above and the Internal Revenue Service determines thereafter that some portion of the Payment is subject to the Excise Tax, Eligible Employee agrees to promptly return
to the Company a sufficient amount of the Payment (after reduction pursuant to clause (x) above) so that no portion of the remaining Payment is subject to the Excise Tax. For the avoidance of doubt, if the Reduced Amount was determined pursuant
to clause (y) above, the Eligible Employee shall have no obligation to return any portion of the Payment pursuant to the preceding sentence. 

Section 4. RETURN OF COMPANY PROPERTY.  

An Eligible Employee will not be entitled to any severance benefit under the Plan unless and until the Eligible Employee returns all Company
Property. For this purpose, “Company Property” means all paper and electronic Company documents (and all copies thereof) and other Company property which the Eligible Employee had in his or her possession or control at any
time, including, but not limited to, Company files, notes, drawings, records, plans, forecasts, reports, studies, analyses, proposals, agreements, financial information, research and development information, sales and marketing information,
operational and personnel information, specifications, code, software, databases, computer-recorded information, tangible property and equipment (including, but not limited to, computers, facsimile machines, mobile telephones, servers), credit
cards, entry cards, identification badges and keys; and any materials of any kind which contain or embody any proprietary or confidential information of the Company (and all reproductions thereof in whole or in part). As a condition to receiving
benefits under the Plan, an Eligible Employee must not make or retain copies, reproductions or summaries of any such Company documents, materials or property. However, an Eligible Employee is not required to return his or her personal copies of
documents evidencing the Eligible Employee’s hire, 

  
 7. 

 
termination, compensation, benefits and stock options and any other documentation received as a stockholder of the Company. 

 

	Section	 5. TIME OF PAYMENT AND FORM
OF BENEFITS. 

 The Company reserves the right in the Participation Agreement to specify
whether payments under the Plan will be paid in a single sum, in installments, or in any other form and to determine the timing of such payments. All such payments under the Plan will be subject to applicable withholding for federal, state, foreign,
provincial and local taxes. All benefits provided under the Plan are intended to satisfy the requirements for an exemption from application of Section 409A to the maximum extent that an exemption is available and any ambiguities herein shall be
interpreted accordingly; provided, however, that to the extent such an exemption is not available, the benefits provided under the Plan are intended to comply with the requirements of Section 409A to the extent necessary to avoid adverse
personal tax consequences and any ambiguities herein shall be interpreted accordingly. 
 It is intended that (i) each installment of
any benefits payable under the Plan to an Eligible Employee be regarded as a separate “payment” for purposes of Treasury Regulations Section 1.409A-2(b)(2)(i), (ii) all payments of any such
benefits under the Plan satisfy, to the greatest extent possible, the exemptions from the application of Section 409A provided under Treasury Regulations Sections 1.409A-1(b)(4), 1.409A-1(b)(5) and 1.409A-1(b)(9)(iii), and (iii) any such benefits consisting of COBRA premiums also satisfy, to the greatest extent possible, the exemption from the
application of Section 409A provided under Treasury Regulations Section 1.409A-1(b)(9)(v). However, if the Company determines that any severance benefits payable under the Plan constitute
“deferred compensation” under Section 409A and the Eligible Employee is a “specified employee” of the Company, as such term is defined in Section 409A(a)(2)(B)(i), then, solely to the extent necessary to avoid the
imposition of the adverse personal tax consequences under Section 409A, (A) the timing of such severance benefit payments shall be delayed until the earlier of (1) the date that is six months and one day after the Eligible
Employee’s Separation from Service and (2) the date of the Eligible Employee’s death (such applicable date, the “Delayed Initial Payment Date”), and (B) the Company shall (1) pay the Eligible Employee
a lump sum amount equal to the sum of the severance benefit payments that the Eligible Employee would otherwise have received through the Delayed Initial Payment Date if the commencement of the payment of the severance benefits had not been delayed
pursuant to this paragraph and (2) commence paying the balance, if any, of the severance benefits in accordance with the applicable payment schedule. 

In no event shall payment of any severance benefits under the Plan be made prior to an Eligible Employee’s Separation from Service or
prior to the effective date of the Release. If the Company determines that any severance payments or benefits provided under the Plan constitute “deferred compensation” under Section 409A, and the Eligible Employee’s Separation
from Service occurs at a time during the calendar year when the Release could become effective in the calendar year following the calendar year in which the Eligible Employee’s Separation from Service occurs, then regardless of when the Release
is returned to the Company and becomes effective, the Release will not be deemed effective, solely for purposes of the timing of payment of severance benefits under this Plan, any earlier than the latest permitted effective date (the
“Release Deadline”). If the Company determines that any severance payments or benefits 

  
 8. 

 
provided under the Plan constitute “deferred compensation” under Section 409A, then except to the extent that severance payments may be delayed until the Delayed Initial Payment
Date pursuant to the preceding paragraph, on the first regular payroll date following the effective date of an Eligible Employee’s Release, the Company shall (1) pay the Eligible Employee a lump sum amount equal to the sum of the severance
benefit payments that the Eligible Employee would otherwise have received through such payroll date but for the delay in payment related to the effectiveness of the Release and (2) commence paying the balance, if any, of the severance benefits
in accordance with the applicable payment schedule. 
 Section 6. TRANSFER AND ASSIGNMENT. 

The rights and obligations of an Eligible Employee under this Plan may not be transferred or assigned without the prior written consent of the
Company. This Plan shall be binding upon any entity or person who is a successor by merger, acquisition, consolidation or otherwise to the business formerly carried on by the Company without regard to whether or not such entity or person actively
assumes the obligations hereunder and without regard to whether or not a Change in Control occurs. 
 Section 7. MITIGATION. 

 Except as otherwise specifically provided in the Plan, an Eligible Employee will not be required to mitigate damages or the amount of any
payment provided under the Plan by seeking other employment or otherwise, nor will the amount of any payment provided for under the Plan be reduced by any compensation earned by an Eligible Employee as a result of employment by another employer or
any retirement benefits received by such Eligible Employee after the date of the Eligible Employee’s termination of employment with the Company. 

Section 8. CLAWBACK; RECOVERY.  

All payments and severance benefits provided under the Plan will be subject to recoupment in accordance with any clawback policy that the
Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company’s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer
Protection Act or other applicable law. In addition, the Plan Administrator may impose such other clawback, recovery or recoupment provisions as the Plan Administrator determines necessary or appropriate, including but not limited to a reacquisition
right in respect of previously acquired shares of common stock of the Company or other cash or property upon the occurrence of a termination of employment for Cause. No recovery of compensation under such a clawback policy will be an event giving
rise to a right to resign for Good Reason, constructive termination, or any similar term under any plan of or agreement with the Company. 

Section 9. RIGHT TO INTERPRET AND ADMINISTER PLAN;
AMENDMENT AND TERMINATION. 
 (a) Interpretation and Administration. Prior to
the Closing, the Committee shall be the Plan Administrator and shall have the exclusive discretion and authority to establish rules, forms, and procedures for the administration of the Plan and to construe and interpret the Plan and to decide any
and all questions of fact, interpretation, definition, computation or 

  
 9. 

 
administration arising in connection with the operation of the Plan, including, but not limited to, the eligibility to participate in the Plan and amount of benefits paid under the Plan. The
rules, interpretations, computations and other actions of the Committee shall be binding and conclusive on all persons. Upon and after the Closing, the Plan will be interpreted and administered in good faith by the Representative who shall be the
Plan Administrator during such period. All actions taken by the Representative in interpreting the terms of the Plan and administering the Plan upon and after the Closing will be final and binding on all Eligible Employees. Any references in this
Plan to the “Committee” or “Plan Administrator” with respect to periods following the Closing shall mean the Representative. 

(b) Amendment. The Plan Administrator reserves the right to amend this Plan at any time; provided, however, that any
amendment of the Plan will not be effective as to a particular employee who is or may be adversely impacted by such amendment or termination and has an effective Participation Agreement without the written consent of such employee. 

(c) Termination. Unless otherwise extended by the Committee, the Plan will automatically terminate following satisfaction of all
the Company’s obligations under the Plan. 
 Section 10. NO IMPLIED EMPLOYMENT
CONTRACT. 
 The Plan shall not be deemed (i) to give any employee or other person any right to be retained in the
employ of the Company or (ii) to interfere with the right of the Company to discharge any employee or other person at any time, with or without cause, which right is hereby reserved. This Plan does not modify the
at-will employment status of any Eligible Employee. 
 Section 11. LEGAL
CONSTRUCTION. 
 This Plan is intended to be governed by and shall be construed in accordance with the Employee Retirement
Income Security Act of 1974 (“ERISA”) and, to the extent not preempted by ERISA, the laws of the State of California. 

Section 12. CLAIMS, INQUIRIES AND APPEALS.  

(a) Applications for Benefits and Inquiries. Any application for benefits, inquiries about the Plan or inquiries about present or
future rights under the Plan must be submitted to the Plan Administrator in writing by an applicant (or his or her authorized representative). The Plan Administrator is: 

PhaseBio Pharmaceuticals, Inc. 

Compensation Committee of the Board of Directors or Representative 

Attention to: Corporate Secretary 

1 Great Valley Parkway, Suite 30 

Malvern, Pennsylvania 19355 

(b) Denial of Claims. In the event that any application for benefits is denied in whole or in part, the Plan Administrator must
provide the applicant with written or electronic notice of the denial of the application, and of the applicant’s right to review the denial. Any electronic notice will comply with the regulations of the U.S. Department of Labor. The notice of

  
 10. 

 
denial will be set forth in a manner designed to be understood by the applicant and will include the following: 

(1) the specific reason or reasons for the denial; 

(2) references to the specific Plan provisions upon which the denial is based; 

(3) a description of any additional information or material that the Plan Administrator needs to complete the review and an explanation
of why such information or material is necessary; and 
 (4) an explanation of the Plan’s review procedures and the time limits
applicable to such procedures, including a statement of the applicant’s right to bring a civil action under Section 502(a) of ERISA following a denial on review of the claim, as described in Section 10(d) below. 

This notice of denial will be given to the applicant within 90 days after the Plan Administrator receives the application, unless special
circumstances require an extension of time, in which case, the Plan Administrator has up to an additional 90 days for processing the application. If an extension of time for processing is required, written notice of the extension will be furnished
to the applicant before the end of the initial 90 day period. 
 This notice of extension will describe the special circumstances
necessitating the additional time and the date by which the Plan Administrator is to render its decision on the application. 
 (c)
Request for a Review. Any person (or that person’s authorized representative) for whom an application for benefits is denied, in whole or in part, may appeal the denial by submitting a request for a review to the Plan Administrator
within 60 days after the application is denied. A request for a review shall be in writing and shall be addressed to: 
 PhaseBio
Pharmaceuticals, Inc. 
 Compensation Committee of the Board of Directors or Representative 

Attention to: Corporate Secretary 

1 Great Valley Parkway, Suite 30 

Malvern, Pennsylvania 19355 
 A request for review
must set forth all of the grounds on which it is based, all facts in support of the request and any other matters that the applicant feels are pertinent. The applicant (or his or her representative) shall have the opportunity to submit (or the Plan
Administrator may require the applicant to submit) written comments, documents, records, and other information relating to his or her claim. The applicant (or his or her representative) shall be provided, upon request and free of charge, reasonable
access to, and copies of, all documents, records and other information relevant to his or her claim. The review shall take into account all comments, documents, records and other information submitted by the applicant (or his or her representative)
relating to the claim, without regard to whether such information was submitted or considered in the initial benefit determination. 

  
 11. 

 (d) Decision on Review. The Plan Administrator will act on each request for
review within 60 days after receipt of the request, unless special circumstances require an extension of time (not to exceed an additional 60 days), for processing the request for a review. If an extension for review is required, written notice of
the extension will be furnished to the applicant within the initial 60 day period. This notice of extension will describe the special circumstances necessitating the additional time and the date by which the Plan Administrator is to render its
decision on the review. The Plan Administrator will give prompt, written or electronic notice of its decision to the applicant. Any electronic notice will comply with the regulations of the U.S. Department of Labor. In the event that the Plan
Administrator confirms the denial of the application for benefits in whole or in part, the notice will set forth, in a manner calculated to be understood by the applicant, the following: 

(1) the specific reason or reasons for the denial; 

(2) references to the specific Plan provisions upon which the denial is based; 

(3) a statement that the applicant is entitled to receive, upon request and free of charge, reasonable access to, and copies of, all
documents, records and other information relevant to his or her claim; and 
 (4) a statement of the applicant’s right to bring
a civil action under Section 502(a) of ERISA. 
 (e) Rules and Procedures. The Plan Administrator will establish rules and
procedures, consistent with the Plan and with ERISA, as necessary and appropriate in carrying out its responsibilities in reviewing benefit claims. The Plan Administrator may require an applicant who wishes to submit additional information in
connection with an appeal from the denial of benefits to do so at the applicant’s own expense. 
 (f) Exhaustion of
Remedies. No legal action for benefits under the Plan may be brought until the applicant (i) has submitted a written application for benefits in accordance with the procedures described by Section 10(a) above, (ii) has been
notified by the Plan Administrator that the application is denied, (iii) has filed a written request for a review of the application in accordance with the appeal procedure described in Section 10(c) above, and (iv) has been notified
that the Plan Administrator has denied the appeal. Notwithstanding the foregoing, if the Plan Administrator does not respond to an Eligible Employee’s claim or appeal within the relevant time limits specified in this Section 10, the
Eligible Employee may bring legal action for benefits under the Plan pursuant to Section 502(a) of ERISA. 
 Section 13. BASIS
OF PAYMENTS TO AND FROM PLAN. 
 The Plan shall
be unfunded, and all cash payments under the Plan shall be paid only from the general assets of the Company. 

  
 12. 

 Section 14. OTHER PLAN INFORMATION. 

(a) Employer and Plan Identification Numbers. The Employer Identification Number assigned to the Company (which is the “Plan
Sponsor” as that term is used in ERISA) by the Internal Revenue Service is 03-0375697 The Plan Number assigned to the Plan by the Plan Sponsor pursuant to the instructions of the Internal Revenue Service is 504. 

(b) Ending Date for Plan’s Fiscal Year. The date of the end of the fiscal year for the purpose of maintaining the
Plan’s records is December 31. 
 (c) Agent for the Service of Legal Process. The agent for the service of legal process
with respect to the Plan is: 
 PhaseBio Pharmaceuticals, Inc. 

Attention to: Corporate Secretary 

1 Great Valley Parkway, Suite 30 

Malvern, Pennsylvania 19355 
 In addition, service
of legal process may be made upon the Plan Administrator. 
 (d) Plan Sponsor. The “Plan Sponsor” is: 

PhaseBio Pharmaceuticals, Inc. 
 1
Great Valley Parkway, Suite 30 
 Malvern, Pennsylvania 19355 

(610) 981-6500 

(e) Plan Administrator. The Plan Administrator is the Committee prior to the Closing and the Representative upon and following
the Closing. The Plan Administrator’s contact information is: 
 PhaseBio Pharmaceuticals, Inc. 

Compensation Committee of the Board of Directors or Representative 

1 Great Valley Parkway, Suite 30 

Malvern, Pennsylvania 19355 
 The Plan
Administrator is the named fiduciary charged with the responsibility for administering the Plan. 
 Section 15. STATEMENT
OF ERISA RIGHTS. 
 Participants in this Plan (which is a welfare benefit plan sponsored by PhaseBio
Pharmaceuticals, Inc.) are entitled to certain rights and protections under ERISA. If you are an Eligible Employee, you are considered a participant in the Plan and, under ERISA, you are entitled to: 

(a) Receive Information About Your Plan and Benefits 

  
 13. 

 (1) Examine, without charge, at the Plan Administrator’s office and at other
specified locations, such as worksites, all documents governing the Plan and a copy of the latest annual report (Form 5500 Series), if applicable, filed by the Plan with the U.S. Department of Labor and available at the Public Disclosure Room of the
Employee Benefits Security Administration; 
 (2) Obtain, upon written request to the Plan Administrator, copies of documents
governing the operation of the Plan and copies of the latest annual report (Form 5500 Series), if applicable, and an updated (as necessary) Summary Plan Description. The Administrator may make a reasonable charge for the copies; and 

(3) Receive a summary of the Plan’s annual financial report, if applicable. The Plan Administrator is required by law to furnish
each Eligible Employee with a copy of this summary annual report. 
 (b) Prudent Actions by Plan Fiduciaries. In addition to
creating rights for Plan Eligible Employees, ERISA imposes duties upon the people who are responsible for the operation of the employee benefit plan. The people who operate the Plan, called “fiduciaries” of the Plan, have a duty to do so
prudently and in the interest of you and other Eligible Employees and beneficiaries. No one, including your employer, your union or any other person, may fire you or otherwise discriminate against you in any way to prevent you from obtaining a Plan
benefit or exercising your rights under ERISA. 
 (c) Enforce Your Rights. If your claim for a Plan benefit is denied or
ignored, in whole or in part, you have a right to know why this was done, to obtain copies of documents relating to the decision without charge, and to appeal any denial, all within certain time schedules. 

Under ERISA, there are steps you can take to enforce the above rights. For instance, if you request a copy of Plan documents or the latest
annual report from the Plan, if applicable, and do not receive them within 30 days, you may file suit in a Federal court. In such a case, the court may require the Plan Administrator to provide the materials and pay you up to $110 a day until you
receive the materials, unless the materials were not sent because of reasons beyond the control of the Plan Administrator. 
 If you have a
claim for benefits which is denied or ignored, in whole or in part, you may file suit in a state or Federal court. 
 If you are
discriminated against for asserting your rights, you may seek assistance from the U.S. Department of Labor, or you may file suit in a Federal court. The court will decide who should pay court costs and legal fees. If you are successful, the court
may order the person you have sued to pay these costs and fees. If you lose, the court may order you to pay these costs and fees, for example, if it finds your claim is frivolous. 

(d) Assistance with Your Questions. If you have any questions about the Plan, you should contact the Plan Administrator. If you
have any questions about this statement or about your rights under ERISA, or if you need assistance in obtaining documents from the Plan Administrator, you should contact the nearest office of the Employee Benefits Security Administration, U.S.
Department of Labor, listed in your telephone directory or the Division of 

  
 14. 

 
Technical Assistance and Inquiries, Employee Benefits Security Administration, U.S. Department of Labor, 200 Constitution Avenue N.W., Washington, D.C. 20210. You may also obtain certain
publications about your rights and responsibilities under ERISA by calling the publications hotline of the Employee Benefits Security Administration. 

  
 15. 

 APPENDIX A 

PARTICIPATION AGREEMENT 

Name: ___________________ 
 Section 1.
ELIGIBILITY.  
 You have been designated as eligible to participate in the PhaseBio Pharmaceuticals, Inc. Severance
Benefit Plan (the “Plan”), a copy of which is attached to this Participation Agreement (the “Participation Agreement”). Capitalized terms not explicitly defined in this Participation Agreement but
defined in the Plan shall have the same definitions as in the Plan. You will receive the benefits set forth below if you meet all the eligibility requirements set forth in the Plan, including, without limitation, executing the required Release
within the applicable time period set forth therein and allowing such Release to become effective in accordance with its terms. Notwithstanding the schedule for provision of benefits as set forth below, the schedule and timing of payment of any
benefits under this Participant Agreement is subject to any delay in payment that may be required under Section 5 of the Plan. 
 Section 2.
CHANGE IN CONTROL SEVERANCE BENEFITS. 
 If you are terminated
in a Covered Termination that occurs during the Change in Control Period, you will receive the severance benefits set forth in this Section 2. All severance benefits described herein are subject to standard deductions and withholdings. 

(a) Base Salary. You shall receive a cash payment in an amount equal to [______] months (the “Severance
Period”) of payment of your Base Salary. The Base Salary payment will be paid to you in a lump sum cash payment no later than the second regular payroll date following the later of (i) the effective date of the Release or
(ii) the Closing, but in any event not later than March 15 of the year following the year in which your Separation from Service occurs. 

(b) Bonus Payment. You will be entitled to the annual target cash bonus established for you, if any, pursuant to the annual
performance bonus or annual variable compensation plan established by the Board of Directors or Committee (or any authorized committee or designee thereof) for the year in which your Covered Termination occurs. If at the time of the Covered
Termination you are eligible for the annual target cash bonus for the year in which the Covered Termination occurs, but the target percentage (or target dollar amount, if specified as such in the applicable bonus plan) for such bonus has not yet
been established for such year, the target percentage shall be the target percentage established for you for the preceding year (but adjusted, if necessary for your position for the year in which the Covered Termination occurs). For the avoidance of
doubt, the amount of the annual target bonus to which you are entitled under this Section 2(b) will be calculated (1) assuming all articulated performance goals for such bonus (including, but not limited to, corporate and individual
performance, if applicable), for the year of the Covered Termination was achieved at target levels; (2) as if you had provided services for the entire year for which the bonus relates; and (3) ignoring any reduction in your Base Salary
that would give rise to your right to resignation for Good Reason (such bonus to which you are entitled under this Section 2(b), the “Annual Target Bonus Severance Payment”). The Annual Target

 
Bonus Severance Payment shall be paid in a lump sum cash payment no later than the second regular payroll date following the later of (i) the effective date of the Release or (ii) the
Closing, but in any event not later than March 15 of the year following the year in which your Separation from Service occurs. 

(a) Payment of Continued Group Health Plan Benefits. If you timely elect continued group health plan continuation coverage under
the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) following your Covered Termination date, the Company shall pay directly to the carrier the full amount of your COBRA premiums on behalf of you for your
continued coverage under the Company’s group health plans, including coverage for your eligible dependents, until the earliest of (i) the end of the Severance Period following the date of your Covered Termination, (ii) the expiration
of your eligibility for the continuation coverage under COBRA, or (iii) the date when you become eligible for substantially equivalent health insurance coverage in connection with new employment (such period from your termination date through
the earliest of (i) through (iii), the “COBRA Payment Period”). Upon the conclusion of such period of insurance premium payments made by the Company, you will be responsible for the entire payment of premiums (or payment
for the cost of coverage) required under COBRA for the duration of your eligible COBRA coverage period, if any. For purposes of this Section, (1) references to COBRA shall be deemed to refer also to analogous provisions of state law and
(2) any applicable insurance premiums that are paid by the Company shall not include any amounts payable by you under an Internal Revenue Code Section 125 health care reimbursement plan, which amounts, if any, are your sole responsibility.
You agree to promptly notify the Company as soon as you become eligible for health insurance coverage in connection with new employment or self-employment. 

Notwithstanding the foregoing, if at any time the Company determines, in its sole discretion, that it cannot provide the COBRA premium
benefits without potentially incurring financial costs or penalties under applicable law (including, without limitation, Section 2716 of the Public Health Service Act), then in lieu of paying COBRA premiums directly to the carrier on your
behalf, the Company will instead pay you on the last day of each remaining month of the COBRA Payment Period a fully taxable cash payment equal to the value of your monthly COBRA premium for the first month of COBRA coverage, subject to applicable
tax withholding (such amount, the “Special Severance Payment”), such Special Severance Payment to be made without regard to your election of COBRA coverage or payment of COBRA premiums and without regard to your continued
eligibility for COBRA coverage during the COBRA Payment Period. Such Special Severance Payment shall end upon expiration of the COBRA Payment Period. 

(c) Equity Acceleration. The vesting and exercisability of each outstanding unvested stock option and other stock award, as
applicable, that you hold covering Company common stock (each, an “Equity Award”) shall be accelerated in full and any reacquisition or repurchase rights held by the Company in respect of common stock issued pursuant to any
Equity Award granted to you shall lapse in full. For purposes of determining the number of shares that will vest pursuant to the foregoing provision with respect to any performance based vesting Equity Award for which the performance period has not
ended and that has multiple vesting levels depending upon the level of performance, vesting acceleration with respect to any ongoing performance period(s) shall occur with respect to the number of shares subject to the award as if the applicable
performance criteria had been attained at a 100% level or, if greater, based on actual 

  
 2. 

 
performance as of your Covered Termination. Notwithstanding anything to the contrary set forth herein, your Equity Awards shall remain subject to the terms of the Equity Plan (or other applicable
Company plan) and award documents under which such Equity Award was granted, including any provision for earlier termination of such Equity Awards. 

(d) Extension of Post-Termination Exercise Period. All outstanding Equity Awards which carry a right to exercise that you hold as
of the date of your Covered Termination will expire on the earlier of (A) the original term of such outstanding Equity Awards as set forth in the applicable award agreement or the equity incentive plan, subject to earlier termination in the
event of a Change in Control as set forth in the terms of the applicable equity incentive plan and definitive agreement for such Change in Control transaction, and (B) the date which occurs on the first anniversary of your Covered Termination.

 Section 3. NON-CHANGE IN
CONTROL SEVERANCE BENEFITS. If you are terminated in a Covered Termination that occurs at a time that is not during the Change in Control Period, you will receive: 

(a) the base salary cash payment described in Section 2(a) above, but the Severance Period for purposes of calculating such
benefits shall be [______] months; and 
 (b) the COBRA benefits described in Section 2(c) above, but the Severance Period for
purposes of calculating such benefits shall be [______] months. 
 You shall not be eligible to receive any other benefits under the Plan except a described
in Section 2(a) and Section 2(c) above. 
 For the avoidance of doubt, in no event shall you be entitled to benefits under both Section 2 and
this Section 3. If you are eligible for severance benefits under both Section 2 and this Section 3, you shall receive the benefits set forth in Section 2 and such benefits shall be reduced by any benefits previously provided to
you under Section 3. 
 Section 4. ACKNOWLEDGEMENTS. 

As a condition to participation in the Plan, you hereby acknowledge each of the following: 

(a) The benefits that may be provided to you under this Participation Agreement are subject to certain reductions and termination under
Section 2 and Section 3 of the Plan. 
 (b) Your eligibility for and receipt of any severance benefits to which you may
become entitled as described in Section 2 or Section 3 above is expressly contingent upon your execution of and compliance with the terms and conditions of the Plan, the Release and the Confidentiality Agreement. Severance benefits under
this Participation Agreement shall immediately cease in the event of your violation of the provisions of Confidentiality Agreement or any other written agreement with the Company. 

(c) As further described in Section 2(c) of the Plan, this Participation Agreement and the Plan supersede and replace any change in
control or severance benefits 

  
 3. 

 
previously provided to you, including but not limited to the benefits under the PhaseBio Pharmaceuticals, Inc. Change in Control Severance Benefit Plan and by executing below you expressly agree
to such treatment. 
 To accept the terms of this Participation Agreement and participate in the Plan, please sign and date this Agreement in the space
provided below and return it to
                                         
        no later than                             ,
                . 
 PhaseBio Pharmaceuticals, Inc. 

 

			
	By:	 	  

	
	  

	  

 Eligible Employee 
  

	
	  

	[Insert Name]

  

			
	Date:	 	  

  
 4.ABERDEEN STANDARD PLATINUM ETF TRUST 8-K

 

Exhibit 10.1

 

Execution Version

AMENDMENT TO THE

ALLOCATED ACCOUNT AGREEMENT

OF

ETFS PLATINUM TRUST

This Amendment
to the Allocated Account Agreement (this “Amendment”) of the ETFS Platinum Trust (the “Trust”),
dated as of October 1, 2018, is made by and between JPMorgan Chase Bank, N.A., as the custodian of the Trust (the “Custodian”),
and The Bank of New York Mellon, a New York banking corporation, as the trustee of the Trust (the “Trustee”).

WITNESSETH THAT:

WHEREAS, the Custodian
and the Trustee are parties to the Allocated Account Agreement (the “Agreement”), dated as of December 30, 2009,
which established an allocated platinum account in the Trustee’s name for the Trust; and

WHEREAS, pursuant
to Section 15.5 of the Agreement, the Custodian and the Trustee desire to amend the Agreement so as to change the names of the
Trust and the shares issuable by the Trust as follows:

 

	Current Name	New Name
	ETFS Platinum Trust	Aberdeen Standard Platinum ETF Trust
	ETFS Physical Platinum Shares 	Aberdeen Standard Physical Platinum Shares ETF

 

; and to reflect the change
in the name of the Sponsor from “ETFS Securities USA LLC” to “Aberdeen Standard Investments ETFs Sponsor LLC”.

 

NOW, THEREFORE, in consideration
of the premises and the agreements hereinafter set forth, the parties hereby agree as follows:

 

1.

(a)

Amendment to the Preamble. The second paragraph of the preamble is hereby deleted in its entirety and replaced with
the following:

 

    -1-

     

    

 

(2)

THE
BANK OF NEW YORK MELLON, a New York banking corporation, solely in its capacity as trustee of the Aberdeen Standard Platinum ETF
Trust created under the Trust Agreement identified below and not individually (the “Trustee”), which expression
shall, wherever the context so admits, include the named Trustee and all other persons or companies for the time being the trustee
or trustees of the Trust Agreement (as defined below) as trustee for the Shareholders (as defined below).

 

(b) 

Amendment
to Section 1.1 of the Agreement. The defined terms for “Shares,” “Sponsor,” “Trust” and
“Trust Agreement” in Section 1.1 of the Agreement are hereby deleted in their entirety and replaced with the following:

 

“Shares” means
the units of fractional undivided beneficial interest in and ownership of the Trust which are issued by the Trust, named “Aberdeen
Standard Physical Platinum Shares ETF” and created pursuant to and constituted by the Trust Agreement;

“Sponsor” means
Aberdeen Standard Investments ETFs Sponsor LLC, its successors and assigns and any successor Sponsor appointed pursuant to the
Trust Agreement;

“Trust” means the
Aberdeen Standard Platinum ETF Trust formed pursuant to the Trust Agreement;

“Trust Agreement”
means the Depositary Trust Agreement of the Aberdeen Standard Platinum ETF Trust dated on or about December 30, 2009, as amended
on or about October 1, 2018, and as may be further amended from time to time, between Aberdeen Standard Investments ETFs Sponsor
LLC, as Sponsor, and The Bank of New York Mellon, as Trustee;

(c)

Amendment
to Section 14.3 of the Agreement. The paragraph entitled “The Sponsor” of Section 14.3 of the Agreement is hereby
deleted in its entirety and replaced with the following:

 

The Sponsor:

Aberdeen Standard
Investments ETFs Sponsor LLC

c/o Aberdeen Standard Investments

712 Fifth Avenue, 49th Floor

New York, NY 10019

 

(d)

Amendment
to Textual References in the Agreement.

(i)

All other references to “ETFS Platinum Trust” in the Agreement are hereby deleted and replaced with “Aberdeen
Standard Platinum ETF Trust.”

(ii)    

All
other references to “ETFS Physical Platinum Shares” in the Agreement are hereby deleted and replaced with “Aberdeen
Standard Physical Platinum Shares ETF.”

(iii) 

All
other references to “ETFS Securities USA LLC” in the Agreement are hereby deleted and replaced with “Aberdeen
Standard Investments ETFs Sponsor LLC.”

 

    -2-

     

    

 

2.

The
amendments contemplated by this Amendment shall, upon execution of this Amendment by the Custodian and the Trustee, be effective
as of October 1, 2018, and no further action shall be required to make such amendments effective.

3.

Except
as expressly amended by this Amendment, the Agreement shall remain in full force and effect.

4.

This
Amendment shall be interpreted under, and all rights and duties under this Amendment shall be governed by, English law.

5.

Except
as otherwise specified in this Amendment, or as the context may otherwise require, capitalized terms shall have the meaning ascribed
to them in the Agreement.

6.

This
Amendment may be executed in any number of counterparts, each of which shall be deemed an original, but all such counterparts together
shall constitute one and the same instrument. Facsimile and electronic counterpart signatures shall be acceptable and binding.

7.

Pursuant
to Section 5.5(a) of the Depositary Trust Agreement of the Trust, dated as of December 30, 2009, as amended, the Sponsor hereby
approves of the Trustee entering into this Amendment.

8.

The
Custodian shall advise any Sub-Custodians and Zurich Sub-Custodians it may use pursuant to the terms of the Agreement about the
change in the names of the Trust and the shares issuable by the Trust and in the name of the Sponsor to be made by this Amendment
so that such Sub-Custodians and Zurich Sub-Custodians may update their records accordingly.

 

[remainder of page intentionally
blank]

 

    -3-

     

    

 

IN WITNESS
WHEREOF, the undersigned have executed this Amendment as of the date first set forth above.

 

 

	JPMorgan Chase Bank, N.A.,	 
	as
Custodian	 
	 	 
	 	 
	/s/ Peter L. Smith	 	 
	Name:
Peter L. Smith	 
	Title:
Managing Director	 
	 	 
	 	 
	 	 
	The Bank of New York Mellon,	 
	solely
in its capacity as Trustee and not individually	 
	 	 
	 	 
	/s/ Phyllis A. Cietek	 	 
	Name:
Phyllis A. Cietek	 
	Title:
Vice President	 
	 	 
	 	 
	 	 
	Aberdeen
Standard Investments ETFs Sponsor LLC	 
	(formerly, ETFS Securities USA LLC),	 
	solely as to paragraph 7	 
	 	 
	 	 
	/s/ Lucia Sitar	 	 
	Name:
Lucia Sitar	 
	Title:
Vice President	 

 

 

[Signature Page to Amendment to
Allocated Account Agreement]

 

    -4-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00288-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00288-of-00352.parquet"}]]